With a market cap. of $34.6 billion, Kenvue Inc. (KVUE) is the world’s largest pure-play consumer health company by revenue, with more than a century of heritage and a portfolio of iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®. Driven by science-backed innovation and recommendations from healthcare professionals worldwide, Kenvue is committed to empowering consumers through everyday care and building trusted relationships in homes around the world.
Kenvue is slated to announce its fiscal Q3 2026 results soon. Ahead of the event, analysts expect KVUE to report an adjusted EPS of $0.28, in line with the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the last four quarterly reports while missing on another occasion.
